Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision updated to v3.4.2 from v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T15:42:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:17:06.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Glossary UI options (Show glossary / Hide glossary) were added. Metadata lines were updated to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while the older QC-related entry and Revision: v3.3.4 were removed.
    Difference
    0.4%
    Check dated 2026-01-23T04:47:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4; Deleted Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T01:12:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added a footer note 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.
    Difference
    0.1%
    Check dated 2025-12-18T21:04:55.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2 (metadata) and no substantive study content changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-27T04:05:35.000Z thumbnail image

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.